Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Immune Disorders » Autoimmune Disorders: Symptoms, Diagnosis and Treatment Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Recycling and Reuse of Materials
$95.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266
Tell A Friend
 
Tell someone you know about this product.
Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266 $100.00
Authors:  (E.W. Brenu, L. Tajouri, D.R. Staines, S. Marshall-Gradisnik, Faculty of Health Science and Medicine, Population Health and Neuroimmunology Unit, Bond University, Robina, Queensland, Australia, and others)
Abstract:
Immunomodulation and immunosuppression are important strategies for monitoring autoimmune disorders. As imbalances in immune function affect other physiological processes, immunomodulators may have an important role in restoring and maintaining regular neuroimmue activities. In recent years these agents have demonstrated important benefits in controlling the mechanisms associated with deteriorating central nervous system pathologies such as Multiple Sclerosis (MS), where central and peripheral nervous system immune regulation is impaired. MS is characterized by severe compromises to neuroimmune processes involving changes in immune cell function, soluble proteins and modulation of inflammatory processes. The introduction of therapeutic agents in the form of immunomodulators; interferon, phosphodiesterase inhibitors and Glatiramer acetate have proven to be useful to some extent in reducing the severity of MS. Herein the implications and effects of these molecules on the immune system in MS are reviewed. Additionally, the available evidence on the mode of action of neuropeptides in MS, their effectiveness on clinical measures, and current knowledge are also reviewed. 


Available Options:
Version:
Special Focus Titles
01.Essays on the Philosophical Nexus between Religion and Politics. Volume 2
02.Glaciology for Glacial Geologists
03.Tropical Fruits: From Cultivation to Consumption and Health Benefits, Fruits from the Amazon
04.The Copper Garden: New Zealand Novels
05.Informed Parents, Healthy Kids: Information You Need to Know to Find the Right Mental Health Practitioner
06.An Echo of Silence: A Comprehensive Research Study on Early Child Marriage (ECM) in Iran
07.Panic Disorder: Assessment, Management and Research Insights
08.Multiple Sclerosis in Children and Adolescents
09.Parkinsonís Disease: Awareness among Young Adults
10.Cancer and Exercise
11.Psychobiological, Clinical, and Educational Aspects of Giftedness
12.Why 40%-80% of Chronic Pain Patients Are Misdiagnosed and How to Correct That

Nova Science Publishers
© Copyright 2004 - 2018

Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266